Similar articles

• GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial.

  Cursiefen C, Bock F, Horn FK, Kruse FE, Seitz B, Borderie V, Früh B, Thiel MA, Wilhelm F, Geudelin B, Descohand I, Steuhl KP, Hahn A, Meller D. Cursiefen C, et al. Ophthalmology. 2009 Sep;116(9):1630-7. doi: 10.1016/j.ophtha.2009.04.016. Epub 2009 Jul 29. Ophthalmology. 2009. PMID: 19643487 Clinical Trial.
• Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study.

  Cursiefen C, Viaud E, Bock F, Geudelin B, Ferry A, Kadlecová P, Lévy M, Al Mahmood S, Colin S, Thorin E, Majo F, Frueh B, Wilhelm F, Meyer-Ter-Vehn T, Geerling G, Böhringer D, Reinhard T, Meller D, Pleyer U, Bachmann B, Seitz B. Cursiefen C, et al. Ophthalmology. 2014 Sep;121(9):1683-92. doi: 10.1016/j.ophtha.2014.03.038. Epub 2014 May 6. Ophthalmology. 2014. PMID: 24811963 Clinical Trial.
• [Topical inhibition of angiogenesis at the cornea. Safety and efficacy].

  Regenfuss B, Bock F, Bachmann B, König Y, Hos D, Parthasarathy A, Cursiefen C. Regenfuss B, et al. Ophthalmologe. 2009 May;106(5):399-406. doi: 10.1007/s00347-009-1934-0. Ophthalmologe. 2009. PMID: 19396447 Review. German.
• The effect of curcumin on corneal neovascularization in rabbit eyes.

  Kim JS, Choi JS, Chung SK. Kim JS, et al. Curr Eye Res. 2010 Apr;35(4):274-80. doi: 10.3109/02713680903528345. Curr Eye Res. 2010. PMID: 20373893
• Corticosteroids as antiangiogenic agents.

  Oliver A, Ciulla TA. Oliver A, et al. Ophthalmol Clin North Am. 2006 Sep;19(3):345-51, v. doi: 10.1016/j.ohc.2006.05.002. Ophthalmol Clin North Am. 2006. PMID: 16935209 Review.